Garware Meditech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-01-2025
- Paid Up Capital ₹ 0.10 M
as on 11-01-2025
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 125.00%
(FY 2022)
- Ebitda 57.50%
(FY 2022)
- Net Worth 4.47%
(FY 2022)
- Total Assets 44.81%
(FY 2022)
About Garware Meditech
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vayu Garware, Milind Kamat, and Santosh Purohit serve as directors at the Company.
- CIN/LLPIN
U18109PN2011PTC141536
- Company No.
141536
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 2011
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Garware Meditech?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vayu Garware | Director | 02-Dec-2011 | Current |
Milind Kamat | Director | 30-Mar-2017 | Current |
Santosh Purohit | Director | 30-Mar-2017 | Current |
Financial Performance of Garware Meditech.
Garware Meditech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 125% increase in profit. The company's net worth moved up by a moderate rise of 4.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Garware Meditech?
In 2021, Garware Meditech had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Garware Technical Textile Private LimitedActive 4 years 3 months
Vayu Garware and Santosh Purohit are mutual person
- Garware Infrastructure Private LimitedActive 17 years 4 months
Vayu Garware, Milind Kamat and 1 more are mutual person
- Garware Capital Markets LimitedActive 64 years 9 months
Vayu Garware, Milind Kamat and 1 more are mutual person
- Consolidated Agricultural And Dairy Farming Co Pvt LtdActive 50 years 2 months
Vayu Garware is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Garware Meditech?
Unlock and access historical data on people associated with Garware Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Garware Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Garware Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.